Scott Reed - Shoulder Innovations Independent Director
| SI Stock | USD 14.16 0.11 0.77% |
Insider
Scott Reed is Independent Director of Shoulder Innovations since 2015.
| Age | 50 |
| Tenure | 11 years |
| Phone | 858 362-6300 |
| Web | www.silvergatebank.com |
Similar Executives
| Showing other executives | INSIDER Age | ||
| Jack Schlechtweg | SANUWAVE Health Common | 43 | |
| Paul Marr | MDxHealth SA ADR | N/A | |
| Nabeel Ahmed | Outset Medical | 49 | |
| Nathalie MD | Enanta Pharmaceuticals | 58 | |
| Adam Zlotnick | Assembly Biosciences | N/A | |
| Nicole White | Assembly Biosciences | 46 | |
| Gwen Weld | Nautilus Biotechnology | 68 | |
| JeanOlivier Racine | Outset Medical | 42 | |
| James Dara | Nano X Imaging | 56 | |
| Ilung Kim | Nano X Imaging | 65 | |
| Scott Rottinghaus | Enanta Pharmaceuticals | N/A | |
| Matthew Pigeon | Inogen Inc | N/A | |
| Peter Stegagno | SANUWAVE Health Common | 63 | |
| Michael McGarrity | MDxHealth SA ADR | 63 | |
| Iulian Cioanta | SANUWAVE Health Common | 60 | |
| Gilad Yron | Nano X Imaging | 51 | |
| Ran Daniel | Nano X Imaging | 58 | |
| Parag Mallick | Nautilus Biotechnology | 48 | |
| Kevin II | SANUWAVE Health Common | 55 | |
| Sujal Patel | Nautilus Biotechnology | 51 | |
| Martin Vazquez | Outset Medical | 53 | |
Shoulder Innovations Leadership Team
Elected by the shareholders, the Shoulder Innovations' board of directors comprises two types of representatives: Shoulder Innovations inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Shoulder. The board's role is to monitor Shoulder Innovations' management team and ensure that shareholders' interests are well served. Shoulder Innovations' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Shoulder Innovations' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Antonio Martino, Chief Financial Officer of the Company and the Bank | ||
| Thomas Dircks, Independent Director | ||
| Alan Lane, President, Chief Executive Officer, Director | ||
| Robert Campbell, Lead Independent Director | ||
| Scott Reed, Independent Director | ||
| Colleen Sullivan, Independent Director | ||
| Rebecca Rettig, Director | ||
| John Bonino, Executive Vice President and Chief Legal Officer of the Company and the Bank | ||
| Derek Eisele, Executive Vice President of the Company, Chief Credit Officer of the Bank | ||
| Elaine Batlis, Exec Division | ||
| Paul Colucci, Independent Director | ||
| Dennis Frank, Chairman of the Board | ||
| Michael Lempres, Chairman of the Board | ||
| Kathleen Fraher, Executive Vice President and Chief Operating Officer of the Company and the Bank | ||
| Hunter Stenback, Head Relations | ||
| Judith Knowles, Sec | ||
| Karen Brassfield, Independent Director | ||
| Aanchal Gupta, Independent Director | ||
| W Simmons, Executive Vice President of the Company and Executive Vice President and Chief Credit Officer of the Bank | ||
| Benjamin Reynolds, Executive Vice President of the Company and Executive Vice President and Director of Corporate Development of the Bank | ||
| SonJai Paik, Chief Human Resources Officer of the Company and the Bank | ||
| Alaric Eby, Chief Officer |
Shoulder Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Shoulder Innovations a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Current Valuation | 219.75 M | ||||
| Shares Outstanding | 14 M | ||||
| Price To Earning | 16.52 X | ||||
| Price To Sales | 6.51 X | ||||
| EBITDA | (870.23 M) | ||||
| Net Income | (937.91 M) | ||||
| Cash And Equivalents | 2.04 B | ||||
| Cash Per Share | 64.47 X | ||||
| Total Debt | 4.32 B | ||||
| Debt To Equity | 0.79 % |
Currently Active Assets on Macroaxis
| VGIAX | Vanguard Growth And | |
| XAR | SPDR SP Aerospace | |
| XAR | SPDR SP Aerospace | |
| XAR | SPDR SP Aerospace | |
| ASML | ASML Holding NV |
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Shoulder Innovations. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as various price indices. For more detail on how to invest in Shoulder Stock please use our How to Invest in Shoulder Innovations guide.You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.
Is there potential for Health Care Equipment & Supplies market expansion? Will Shoulder introduce new products? Factors like these will boost the valuation of Shoulder Innovations. If investors know Shoulder will grow in the future, the company's valuation will be higher. Understanding fair value requires weighing current performance against future potential. All the valuation information about Shoulder Innovations listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.91) |
Shoulder Innovations's market price often diverges from its book value, the accounting figure shown on Shoulder's balance sheet. Smart investors calculate Shoulder Innovations' intrinsic value—its true economic worth—which may differ significantly from both market price and book value. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. Since Shoulder Innovations' trading price responds to investor sentiment, macroeconomic conditions, and market psychology, it can swing far from fundamental value.
Please note, there is a significant difference between Shoulder Innovations' value and its price as these two are different measures arrived at by different means. Investors typically determine if Shoulder Innovations is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Shoulder Innovations' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.